Thursday, July 29, 2021

Food and Drug Administration

FDA Warns CBD Companies For Violations

Specifically, the warning letters address the illegal marketing of unapproved drugs labeled as containing CBD.

NIST And FDA May Be the Cannabis Quality Assurance Heroes We Need

There may be some light at the end of the quality assurance tunnel.

Federal Policy On Hemp CBD Is Taking Shape: What Needs To Be Addressed?

One feature that could show up in the FDA's enforcement guidance submitted to the White House is instruction on how to measure THC in hemp products.

What Health Professionals Should Know About Recent FDA Actions On Vaccines

Confirming not only a clear commitment to data, the FDA re-iterated its inclusion of diverse populations in COVID-19 vaccine development.

FDA Guidance On Cannabis Research: A Glimpse Of What’s To Come For CBD Products?

This guidance is merely a reflection of the FDA’s current thinking on the manufacturing and testing of hemp-derived drugs.

How To Find Quality CBD Amid The Craze

The non-intoxicating cannabis derivative has essentially become a household name across the United States as a potential miracle cure for all sorts of ailments.

FDA Issues Draft Guidance For Cannabis Research

The data obtained from these studies may later become part of a new drug application, which is then used to formally propose that FDA...

How The CURE Drug Repurposing Collaboratory Helps COVID-19 Research

A partnership between government agencies is determined to provide researchers with additional dimensions of real-time data for some COVID-19 research.

FOR A WEEKLY DOSE OF THE FRESH TOAST

Hand selected from our editors with all the latest news and entertainment with a side of cannabis.

Follow Us

123,000FansLike
7,000FollowersFollow
6,500FollowersFollow

Latest Articles